2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64

C49H80CuN17O9+ — CID 162303307

IUPAC2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64
SMILESNC(N)=NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCNC(=O)c2ccc(CNC34CNCCNCC(N)(CNCCNC3)CNCC[NH2+]C4)cc2)NC1=O.[64Cu]
InChIInChI=1S/C49H79N17O9.Cu/c50-47(51)60-15-3-5-36-44(73)64-37(45(74)65-38(22-32-8-12-35(67)13-9-32)46(75)66-39(23-41(69)70)43(72)61-25-40(68)63-36)4-1-2-14-59-42(71)34-10-6-33(7-11-34)24-62-49-29-56-19-16-53-26-48(52,27-54-17-20-57-30-49)28-55-18-21-58-31-49;/h6-13,36-39,53-58,62,67H,1-5,14-31,52H2,(H,59,71)(H,61,72)(H,63,68)(H,64,73)(H,65,74)(H,66,75)(H,69,70)(H4,50,51,60);/p+1/t36-,37-,38+,39-,48?,49?;/m1./s1/i;1+0
InChIKeyQYCATRFBYNKREK-FVHAXHKVSA-O
MW1115.22 g/mol
LogP-6.81
Rot. Bonds17

About 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64

2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64 (PubChem CID 162303307) has the molecular formula C49H80CuN17O9+ and a molecular weight of 1115.22 g/mol. Its IUPAC name is 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64.

Molecular Properties

Compound Name2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64
PubChem CID162303307
Molecular FormulaC49H80CuN17O9+
Molecular Weight1115.22 g/mol
Exact Mass1114.56
IUPAC Name2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64
SMILESNC(N)=NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCNC(=O)c2ccc(CNC34CNCCNCC(N)(CNCCNC3)CNCC[NH2+]C4)cc2)NC1=O.[64Cu]
InChIInChI=1S/C49H79N17O9.Cu/c50-47(51)60-15-3-5-36-44(73)64-37(45(74)65-38(22-32-8-12-35(67)13-9-32)46(75)66-39(23-41(69)70)43(72)61-25-40(68)63-36)4-1-2-14-59-42(71)34-10-6-33(7-11-34)24-62-49-29-56-19-16-53-26-48(52,27-54-17-20-57-30-49)28-55-18-21-58-31-49;/h6-13,36-39,53-58,62,67H,1-5,14-31,52H2,(H,59,71)(H,61,72)(H,63,68)(H,64,73)(H,65,74)(H,66,75)(H,69,70)(H4,50,51,60);/p+1/t36-,37-,38+,39-,48?,49?;/m1./s1/i;1+0
InChIKeyQYCATRFBYNKREK-FVHAXHKVSA-O
XLogP-6.81
TPSA411.34 Ų
H-Bond Donors18
H-Bond Acceptors16
Rotatable Bonds17
Heavy Atoms76
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001115.22
LogP ≤ 5-6.81
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64 with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64?
The IUPAC name of 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64 (CID 162303307) is 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64.
What is the SMILES notation for 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64?
The canonical SMILES for 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64 is NC(N)=NCCC[C@H]1NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](CCCCNC(=O)c2ccc(CNC34CNCCNCC(N)(CNCCNC3)CNCC[NH2+]C4)cc2)NC1=O.[64Cu].
What is the InChIKey of 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64?
The InChIKey is QYCATRFBYNKREK-FVHAXHKVSA-O. The full InChI is InChI=1S/C49H79N17O9.Cu/c50-47(51)60-15-3-5-36-44(73)64-37(45(74)65-38(22-32-8-12-35(67)13-9-32)46(75)66-39(23-41(69)70)43(72)61-25-40(68)63-36)4-1-2-14-59-42(71)34-10-6-33(7-11-34)24-62-49-29-56-19-16-53-26-48(52,27-54-17-20-57-30-49)28-55-18-21-58-31-49;/h6-13,36-39,53-58,62,67H,1-5,14-31,52H2,(H,59,71)(H,61,72)(H,63,68)(H,64,73)(H,65,74)(H,66,75)(H,69,70)(H4,50,51,60);/p+1/t36-,37-,38+,39-,48?,49?;/m1./s1/i;1+0.
What are the key properties of 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64?
2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64 has a molecular weight of 1115.22 g/mol, XLogP of -6.81, 17 rotatable bonds, 18 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2R,8R,11R,14S)-11-[4-[[4-[[(8-amino-3,6,10,13,19-pentaza-16-azoniabicyclo[6.6.6]icosan-1-yl)amino]methyl]benzoyl]amino]butyl]-8-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid;copper-64 is sourced from PubChem (CID 162303307), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).